Brought to you by 
OVP Venture Partners leads Limerick's Series C round
10 Jun 2010
Executive Summary
Limerick BioPharma (formerly Limerick NeuroSciences; developing compounds with improved side-effect profiles) raised $15mm in its Series C financing led by OVP Venture Partners, a VC firm that is known for only leading seed and Series A rounds. Returning shareholders Altitude Funds, Arch Venture Partners, and Sevin Rosen Funds also contributed.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
OVP Venture Partners leads Limerick's Series C round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice